Comparison between super-responders and non-super-responders in psoriasis under adalimumab treatment: a real-life cohort study on the effectiveness and drug survival over one-year-Reference-Cited by-同舟云学术

Comparison between super-responders and non-super-responders in psoriasis under adalimumab treatment: a real-life cohort study on the effectiveness and drug survival over one-year

Published:2024-03-21 Issue:1 Volume:35 Page:
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Liu Yizhang¹²³⁴⁵^ORCID,Hu Kun¹²³⁴⁵^ORCID,Jian Lu¹²³⁴⁵^ORCID,Duan Yongfang¹²³⁴⁵^ORCID,Zhang Mi¹²³⁴⁵^ORCID,Kuang Yehong¹²³⁴⁵^ORCID

Affiliation:

1. Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China

2. National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China

3. Furong Laboratory, Changsha, China

4. National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China

5. Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha, China

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2024.2331782

Reference28 articles.

1. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis

2. The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries

3. Quality of life and stigmatization in people with skin diseases in Europe: A large survey from the ‘burden of skin diseases’ EADV project

4. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis

5. Clinical meaningfulness of complete skin clearance in psoriasis